EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Esophageal cancer in China: Practice and research in the new era

Hongcheng Zhu iD, Xiao Ma, Ting Ye, Honggang Wang, Zezhou Wang, Qi Liu, Kuaile Zhao

International Journal of Cancer · 2023-05 · 152 (9) · 1741-1751

DOI: 10.1002/ijc.34301 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Cancer, online erschienen am 05.10.2022. Verfasst von Hongcheng Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: International Cooperation, Esophageal Neoplasms. Die Arbeit wurde bisher 244-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese Society of Clinical Oncology, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

China, as the one of the largest developing countries in the world and with about one‐fifth of the global population, is bearing an increasing burden on health from cancer. In the area of esophageal cancer (EC), China accounts for more than 50% of the global cases, with this disease being a particularly worse for those in disadvantaged populations. Along with China's socioeconomic condition, the epidemiology, diagnosis, therapeutics and research of EC have developed throughout the 21st century. In the current review, existing control measures for EC in China are outlined, including the incidence, mortality, screening, clinical diagnosis, multidisciplinary treatment and research landscape. EC in China are very different from those in some other parts of the world, especially in Western countries. Core measures that could contribute to the prevention of EC and improve clinical outcomes in patients of less developed countries and beyond are recommended. International cooperation among academia, government and industry is especially warranted in global EC control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

International CooperationEsophageal NeoplasmsHumansDelivery of Health CareIncidenceChina

Stichwörter der Autor:innen

Chinadeveloping countryesophageal cancergastrointestinal cancerresearch

Autor:innen und Institutionen

  • Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Gastroenterology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
  • Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Shanghai, China.

ORCID-Profile: Hongcheng Zhu

Förderung

  • Chinese Society of Clinical Oncology
  • National Natural Science Foundation of China

Zitieren

APA

Zhu, H., Ma, X., Ye, T., Wang, H., Wang, Z., Liu, Q., & Zhao, K. (2023). Esophageal cancer in China: Practice and research in the new era. International Journal of Cancer, 152(9), 1741-1751. https://doi.org/10.1002/ijc.34301

Vancouver

Zhu H, Ma X, Ye T, Wang H, Wang Z, Liu Q, et al. Esophageal cancer in China: Practice and research in the new era. International Journal of Cancer. 2023;152(9):1741-1751. doi:10.1002/ijc.34301

BibTeX
@article{Zhu2023,
  author = {Zhu, Hongcheng and Ma, Xiao and Ye, Ting and Wang, Honggang and Wang, Zezhou and Liu, Qi and Zhao, Kuaile},
  title = {Esophageal cancer in China: Practice and research in the new era},
  journal = {International Journal of Cancer},
  year = {2023},
  volume = {152},
  number = {9},
  pages = {1741--1751},
  doi = {10.1002/ijc.34301}
}
Kostenlos starten →